Xiao-Li Zhu (Xiaoli Zhu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Pulmonary Artery

Signaling Pathway

Small Cell Lung Cancer

Top Venues

Canadian respiratory journal

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Le Wang, Lu Xu, Shu-Hua Han, Xiao-Li Zhu
Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway. Canadian respiratory journal 2024 (2024)
Li-Le Wang, Lu Xu, Shu-Hua Han, Xiao-Li Zhu
Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway. Canadian respiratory journal 2024 (2024)
Li-Le Wang, Xiao-Li Zhu, Shu-Hua Han, Lu Xu
Hypoxia Upregulates NOTCH3 Signaling Pathway to Promote Endothelial-Mesenchymal Transition in Pulmonary Artery Endothelial Cells. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)